INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 6 of 116

2020 / Crossover feeding trial

A 5-day isocaloric high-fat diet doubled fasting endotoxin and altered skeletal muscle substrate metabolism without altering gut permeability in young men.

Thirteen healthy young men consumed a control diet for 2 weeks followed by 5 days of an isocaloric high-fat diet (HFD; 55% fat, 25% saturated). Intestinal permeability and responses to a high-fat meal challenge were evaluated before and after the HFD. Intestinal permeability was not affected by the HFD (p > 0.05), but fasting endotoxin increased two-fold (p = 0.04). Skeletal muscle glucose and fatty acid oxidation increased post-meal before the HFD (+97% and +106%) but decreased post-meal after the HFD (-24% and +16%, respectively), while insulin sensitivity remained unchanged.

Bowser SM, McMillan RP, Boutagy NE, et al. Metabolism, 2020. PMID 31785256

2020 / Within-subject controlled trial (contralateral leg design)

Postexercise cold-water immersion reduces dietary protein incorporation and myofibrillar protein synthesis rates following resistance exercise.

Twelve healthy young men performed resistance exercise followed by 20 minutes of leg immersion with one leg in cold water (8°C: CWI) and the other in thermoneutral water (30°C: CON), followed by ingestion of 20 g intrinsically labelled milk protein with 45 g carbohydrates. Incorporation of dietary protein-derived l-[1-13C]-phenylalanine was significantly lower in CWI versus CON (0.016 ± 0.006 vs. 0.021 ± 0.007 MPE; P = 0.016). Acute myofibrillar protein synthesis rates over 5 hours were lower in CWI based on l-[1-13C]-leucine (0.058 ± 0.011 vs. 0.072 ± 0.017% h-1; P = 0.024) and l-[ring-2H5]-phenylalanine (0.042 ± 0.009 vs. 0.053 ± 0.013% h-1; P = 0.025). Furthermore, daily myofibrillar protein synthesis rates over 2 weeks were significantly lower in CWI compared to CON (1.48 ± 0.17 vs. 1.67 ± 0.36% day-1; P = 0.042).

Fuchs CJ, Kouw IWK, Churchward-Venne TA, et al. J Physiol, 2020. PMID 31788800

2020 / Crossover clinical trial

Extra virgin olive oil reduced inflammatory markers and digestive symptoms in patients with ulcerative colitis

In a crossover clinical trial comparing extra virgin olive oil with canola oil, 32 of 40 patients with ulcerative colitis completed two 20-day intervention rounds. Consumption of extra virgin olive oil was followed by significant decreases in erythrocyte sedimentation rate (p = 0.03) and high-sensitivity C-reactive protein (p < 0.001). Bloating, constipation, fecal urgency, incomplete defecation, and final gastrointestinal symptom rating scale scores were also significantly reduced after extra virgin olive oil consumption (p < 0.05).

NANO counterpoint →

Morvaridi M, Jafarirad S, Seyedian SS, et al. Eur J Clin Nutr, 2020. PMID 31901082

2020 / Randomized clinical trial

A behavioral counseling intervention to increase vegetable intake did not significantly reduce the risk of prostate cancer progression in men on active surveillance.

The MEAL randomized trial tested a telephone counseling intervention promoting consumption of 7 or more daily vegetable servings versus written dietary information in 478 men with early-stage prostate cancer. Over 24 months, there were 245 progression events (124 intervention, 121 control), with no significant difference in time to progression (adjusted HR, 0.97 [95% CI, 0.76 to 1.25]). Progression-free percentages at 24 months were 43.5% in the intervention group and 41.4% in the control group (difference, 2.1% [95% CI, -8.1% to 12.2%]). Authors noted the study may have been underpowered to identify a clinically important difference.

Parsons JK, Zahrieh D, Mohler JL, et al. JAMA, 2020. PMID 31935026

2020 / Randomized controlled trial

Revascularization provided no long-term quality of life or walking benefit over exercise therapy and medical therapy alone in intermittent claudication.

The IRONIC trial randomized 158 patients with mild-to-severe intermittent claudication to revascularization plus medical therapy and structured exercise, or medical therapy and structured exercise alone. At 5 years, no significant intergroup differences were observed for SF-36 scores, except for the role emotional domain which favored the nonrevascularization group (P=0.007). There were also no differences in VascuQoL scores or treadmill walking distances, while revascularization incurred nearly double the cost per patient ($13,098 vs $6,965, P=0.02).

Djerf H, Millinger J, Falkenberg M, et al. Circ Cardiovasc Interv, 2020. PMID 31937137

2020 / Randomized crossover trial

Daily non-fried potato consumption improved diet quality without altering glycemic markers in healthy adults.

Fifty healthy adults completed a randomized crossover trial comparing four weeks of daily non-fried potato side dishes against refined grains. Fasting plasma glucose did not differ between treatments (-0.05 mmol/l, 95% CI -0.14 to 0.04, P = 0.15), and no differences emerged for cardiometabolic endpoints. Potato consumption resulted in higher Healthy Eating Index-2015 scores (difference 3.5, 95% CI 0.6 to 6.4), potassium (547 mg, 95% CI 331 to 764), and dietary fiber (2.4 g, 95% CI 0.6 to 4.2).

Johnston EA, Petersen KS, Kris-Etherton PM Br J Nutr, 2020. PMID 31964428

2020 / 3-month self-selection pilot trial

A 3-month pilot study of a watermelon-enhanced anti-inflammatory diet found no group-by-time interactions for body habitus, inflammatory, or metabolic markers.

A 3-month self-selection pilot study evaluated a watermelon-focused Inflammation Management Intervention (n = 15) versus basic health education controls (n = 8). There were no group-by-time interactions for any studied outcomes. Post hoc analyses grouped participants by change in energy-adjusted Dietary Inflammatory Index (E-DII) score, noting that some intervention participants became more proinflammatory and several controls became more anti-inflammatory. Those with more anti-inflammatory dietary changes (below median E-DII change) showed differences in body fat percent (-1.27% vs +0.90%, P = .01), BMI (-0.66 vs +0.38 kg/m2, P = .06), and body weight (-0.99 vs +0.54 kg, P = .08).

Wirth MD, Shivappa N, Khan S, et al. Nutr Metab Insights, 2020. PMID 31975781

2020 / Cluster randomized trial

A potassium-enriched salt substitute significantly increased urinary potassium and reduced systolic blood pressure in rural China.

The Salt Substitute and Stroke Study is an ongoing 5-year cluster randomized trial evaluating potassium-enriched salt substitute versus usual salt in 20,996 individuals across 600 Chinese villages. Intermediate markers assessed over 3 years showed mean differences between the intervention and control groups of -0.32 g (95% CI: -0.68 to 0.05) for 24-hour urinary sodium, +0.77 g (+0.60 to +0.93) for 24-hour urinary potassium, and -2.65 mmHg (-4.32 to -0.97) for systolic blood pressure. Diastolic blood pressure difference was +0.30 mmHg (-0.72 to +1.32). Salt substitute use was 97.5% in the intervention group versus 4.2% in controls, and the overall annual fatal and non-fatal stroke rate across the first 2 years was 3.2%.

Huang L, Tian M, Yu J, et al. Am Heart J, 2020. PMID 31986290

2020 / Randomized controlled trial

Collagen peptide supplementation for 12 weeks did not reduce knee pain or improve function more than placebo in active middle-aged and older adults.

A randomized controlled trial examined the effects of 10 g/day of collagen peptides (CP) versus placebo for 12 weeks in 167 physically active individuals with self-reported knee pain. Both groups experienced similar reductions in VAS pain scores (-1.6 ± 2.4 with CP vs. -1.9 ± 2.6 with placebo, p = 0.42). KOOS and Lysholm function scores increased significantly in both groups (p < 0.001), but the increases did not differ between groups (p = 0.28 and p = 0.76, respectively). CP also showed no effect on inflammatory, cartilage, or bone biomarkers (p > 0.05).

Bongers CCWG, Ten Haaf DSM, Catoire M, et al. Appl Physiol Nutr Metab, 2020. PMID 31990581

2020 / In vitro study and pilot controlled clinical study

In a pilot study of postmenopausal women, consuming lycopene-rich tomato sauce prevented significant bone density loss compared to controls.

Researchers evaluated the in vitro effects of lycopene on Saos-2 osteoblast cells and conducted a pilot controlled trial assessing bone loss prevention via lycopene-rich tomato sauce in 39 postmenopausal women. In vitro, lycopene modulated Wnt/β-catenin, ERK 1/2, RUNX2, COL1A, and RANKL pathways. In the clinical trial, significant bone density loss was not detected in women consuming tomato sauce, whereas controls experienced bone loss (p = 0.002). Tomato sauce intake also led to a greater reduction in bone alkaline phosphatase compared with controls (18% vs 8.5%, p = 0.03).

Russo C, Ferro Y, Maurotti S, et al. J Transl Med, 2020. PMID 31996227

2020 / Controlled feeding studies

Endotoxin may not be the major cause of postprandial inflammation after a high-fat or moderately high-fat meal in healthy adults.

Volunteers consumed either a 60% kcal fat meal (n=98) or a 36% kcal fat meal (n=62, placebo group). At least 87.5% of plasma LPS measurements in 32 tested participants were below the assay sensitivity (0.002 EU/mL). Although polymyxin B suppressed IL-1β (P = 0.035) and IL-6 (P = 0.0487) production in 3 h postprandial blood after 24 h incubation in the 60% fat study, the LPS present did not increase cytokine concentrations above fasting levels. In vitro lipoprotein lipase treatment significantly increased FFA and cytokine concentrations (P < 0.05) in both studies.

Mo Z, Huang S, Burnett DJ, et al. J Nutr, 2020. PMID 32040591

2020 / Randomized crossover trial

Interrupting sitting with stair climbing improved postprandial vascular measures and may help prevent vascular dysfunction after a high-fat meal.

In a randomized crossover trial, 12 healthy adults ate a high-fat meal followed by 4 hours of uninterrupted sitting or sitting interrupted every hour with 5 minutes of stair climbing. Plasma triglycerides and glucose increased after the meal and returned to baseline at the end of both trials. Brachial artery flow-mediated dilation decreased with uninterrupted sitting (9.65 ± 2.63% to 7.84 ± 2.36%) but not with interrupted sitting (9.41 ± 2.61% to 10.34 ± 3.30%, p = 0.009 for interaction). Compared with uninterrupted sitting, the interrupted trial improved popliteal blood flow and shear rate (p = 0.004 and p = 0.008 for interaction, respectively).

Cho MJ, Bunsawat K, Kim HJ, et al. Eur J Appl Physiol, 2020. PMID 32065258

2020 / Cluster randomized trial

Replacing regular salt with potassium-enriched substitute lowered blood pressure and hypertension incidence

A cluster randomized trial in 2,376 participants in Peru evaluated replacing household salt with a 75% sodium chloride and 25% potassium chloride substitute. The intervention reduced systolic blood pressure by 1.29 mm Hg (95% CI -2.17 to -0.41) and diastolic blood pressure by 0.76 mm Hg (95% CI -1.39 to -0.13). Among participants normotensive at baseline, salt substitution was linked to a 51% lower risk of developing hypertension (95% CI 29% to 66%).

Bernabe-Ortiz A, Sal Y Rosas VG, Ponce-Lucero V, et al. Nat Med, 2020. PMID 32066973

2020 / Phase II double-blind randomized placebo-controlled trial

A daily cocoa beverage improved 6-minute walk distance at 2.5 hours post-consumption in older adults with peripheral artery disease.

In a 6-month trial, 44 participants with peripheral artery disease were randomized to consume a daily cocoa beverage (15 g cocoa, 75 mg epicatechin) or a placebo. Adjusting for smoking, race, and BMI, cocoa improved 6-minute walk distance by 42.6 m (90% CI, +22.2 to +∞; P=0.005) at 2.5 hours after a final beverage, and by 18.0 m (90% CI, -1.7 to +∞; P=0.12) at 24 hours post-beverage compared to placebo. Calf muscle biopsies showed cocoa improved mitochondrial cytochrome c oxidase activity (P=0.013), increased capillary density (P=0.014), improved perfusion (P=0.098), and reduced central nuclei (P=0.033).

McDermott MM, Criqui MH, Domanchuk K, et al. Circ Res, 2020. PMID 32078436

2020 / Randomized crossover trial

An alkalizing diet increased blood buffer capacity and pH but did not improve high-intensity anaerobic exercise performance.

In a randomized crossover trial, 15 participants underwent 4 days of an alkalizing (BASE) or acidizing (ACID) diet under normoxic and normobaric hypoxic conditions. Anaerobic exercise performance was evaluated using the portable tethered sprint running (PTSR) test. Urinary pH, blood pH, blood bicarbonate concentration, and base excess were significantly higher following the BASE diet compared with the ACID diet (p < 0.001). However, there were no differences between BASE and ACID conditions for any of the PTSR-related parameters, indicating that diet-induced metabolic changes did not improve anaerobic performance.

Limmer M, Sonntag J, de Marées M, et al. Nutrients, 2020. PMID 32143278

2020 / Randomized double-blind placebo-controlled pilot trial

Weekly oral fecal microbiota transplantation from lean donors did not significantly improve insulin sensitivity or body composition in adults with obesity.

In a 12-week pilot trial, 24 adults with obesity and mild-moderate insulin resistance were randomized to weekly oral FMT capsules from healthy lean donors or placebo for 6 weeks. There were no statistically significant improvements in insulin sensitivity between groups (+5% ± 12% in FMT vs -3% ± 32% in placebo, mean difference 9%, 95% CI -5% to 28%, p = 0.16). Additionally, no significant differences were seen for HOMA-IR (mean difference 0.2, 95% CI -0.9 to 0.9, p = 0.96), lean mass (mean difference -0.1 kg, p = 0.87), or fat mass (mean difference 1.2 kg, p = 0.18). Variable bacterial engraftment persisted throughout 12 weeks with no serious adverse events related to FMT.

Yu EW, Gao L, Stastka P, et al. PLoS Med, 2020. PMID 32150549

2020 / Randomised double-blind, placebo-controlled trial

Four weeks of daily wild blueberry supplementation significantly reduced self-reported depression symptoms in healthy adolescents.

In a randomized, double-blind, placebo-controlled trial, 64 healthy adolescents aged 12-17 were assigned to receive daily wild blueberry (WBB) supplementation containing about 253 mg anthocyanins or a matched placebo for 4 weeks. Following the intervention, participants receiving WBB had significantly fewer self-reported depressive symptoms than those receiving placebo (P = 0.02, 95% CI -6.71, -5.35). No between-group effects were observed for anxiety symptoms or transient affect.

Fisk J, Khalid S, Reynolds SA, et al. Br J Nutr, 2020. PMID 32151287

2020 / Randomized controlled trial

Flaxseed flour supplementation improved constipation symptoms and quality of life more effectively than lactulose in Chinese adults.

A randomized controlled trial evaluated 90 adults with functional constipation assigned to receive either 50 g/day flaxseed flour (n=60) or 15 mL/day lactulose solution (n=30) for 4 weeks. Both groups showed significant improvements in bowel habits. Median Wexner constipation scores fell from 14 to 6.5 in the flaxseed group and 15 to 9 in the lactulose group (both p<0.001). Median weekly defecation frequency rose from 2 to 7 with flaxseed and 2 to 6 with lactulose (both p<0.001), while constipation quality of life scores dropped by -1.34 and -0.66, respectively (both p<0.001).

Sun J, Bai H, Ma J, et al. Asia Pac J Clin Nutr, 2020. PMID 32229443

2020 / Randomized controlled trial

Resveratrol supplementation improved cognitive performance and attenuated the decline in cerebrovascular responsiveness in postmenopausal women.

Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).

Thaung Zaw JJ, Howe PRC, Wong RHX Nutrients, 2020. PMID 32244933

2020 / Randomized, double-blind, placebo-controlled trial

In healthy women, 12 weeks of apple polyphenol supplementation significantly prevented UV irradiation-induced skin pigmentation compared to placebo.

Sixty-five healthy women aged 20-39 years were randomized to receive daily apple polyphenol tablets (300 or 600 mg/day) or a placebo for 12 weeks. Continuous supplementation with apple polyphenols significantly prevented UV irradiation-induced skin pigmentation, including improvements in erythema, melanin, and L values, though a dose-dependent relationship was not clearly observed. No significant differences were detected between the groups regarding skin water content and trans-epidermal water loss.

Shoji T, Masumoto S, Moriichi N, et al. Nutrients, 2020. PMID 32294883

2020 / Interventional pharmacokinetic excretion study

After consuming a test meal with pesticide residues, participants excreted 1% of the glyphosate dose in urine with an elimination half-life of 9 hours.

Twelve participants consumed a test meal containing a known amount of glyphosate residue and a small amount of AMPA, and urinary excretion was monitored for 48 hours. Only 1% of the glyphosate dose was excreted in urine, with an elimination half-life of 9 hours. For AMPA, 23% of the dose was excreted in urine assuming no metabolism of glyphosate to AMPA occurred, or 0.3% on a molar basis if all excreted AMPA was a metabolite. The study provides data to estimate oral glyphosate intake from urinary biomonitoring.

Zoller O, Rhyn P, Zarn JA, et al. Int J Hyg Environ Health, 2020. PMID 32305862

2020 / Randomized, double-blinded, placebo-controlled, crossover trial

Nicotinamide riboside supplementation increased fat-free mass and muscle acetylcarnitine but did not alter insulin sensitivity in overweight or obese adults.

In a randomized, double-blinded, placebo-controlled crossover study, 13 healthy overweight or obese adults received 1000 mg/d nicotinamide riboside (NR) and placebo for 6 weeks each. NR increased skeletal muscle markers of NAD+ synthesis, body fat-free mass (62.65% ± 2.49% vs 61.32% ± 2.58%; change: 1.34% ± 0.50%, P = 0.02), and sleeping metabolic rate. Skeletal muscle acetylcarnitine concentrations increased (4558 ± 749 vs 3025 ± 316 pmol/mg dry weight; change: 1533 ± 683, P = 0.04), along with exercise acetylcarnitine-forming capacity (P = 0.01). However, NR had no effects on insulin sensitivity, mitochondrial function, hepatic/intramyocellular lipid accumulation, cardiac energy status, cardiac ejection fraction, blood pressure, inflammation markers, or energy metabolism.

Remie CME, Roumans KHM, Moonen MPB, et al. Am J Clin Nutr, 2020. PMID 32320006

2020 / Randomized clinical trial

In children, rinsing with an EGCG or green tea mouthwash significantly reduced salivary mutans streptococci and lactobacilli counts.

A randomized trial assessed the antimicrobial efficacy of mouthwashes containing EGCG, green tea, chlorhexidine (CHX), or distilled water rinsed for one minute in 47 children. All rinses significantly reduced counts of mutans streptococci and lactobacilli before versus after rinsing. For mutans streptococci, the percentage reductions were 95.5% for CHX, 79.9% for EGCG, 68.3% for green tea, and 50.6% for distilled water. For lactobacilli, reductions were 86.02% for CHX, 72.09% for EGCG, 59.17% for green tea, and 41.96% for distilled water.

Vilela MM, Salvador SL, Teixeira IGL, et al. Arch Oral Biol, 2020. PMID 32361019

2020 / Randomized controlled intervention study

Vitamin D supplementation raised 25-OH-VitD similarly across three formulations, with higher efficiency seen in adults with lower BMI and lower baseline levels.

In Slovenia during winter, 105 healthy adults with suboptimal vitamin D status (25-OH-VitD 30-50 nmol/L) were randomized to three daily cholecalciferol formulations (1000 IU/25 µg as capsules, oil-based spray, or water-based spray) or a control group for two months. Supplementation significantly increased serum 25-OH-VitD levels compared to control (pooled Δc 32.8 nmol/L; 95% CI: 23.0, 42.5, p < 0.0001), with no significant differences between the formulations. Supplementation efficiency was associated with body mass index and baseline 25-OH-VitD, showing higher efficiency in participants with BMI < 25 and those with more pronounced insufficiency. The tested dosage was not sufficient to reach recommended levels in all subjects.

Žmitek K, Hribar M, Hristov H, et al. Nutrients, 2020. PMID 32365732